Pfizer, Inc. (NYSE: PFE) announced top-line results for a Phase 3 study that showed Lyrica (pregabalin) Capsules CV were as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE